Reyhane Khademi

Drug Repurposing in Sickle Cell Disease: Evaluating Imatinib as a Therapeutic Candidate

Sickle cell disease (SCD) is an inherited hemolytic hemoglobinopathy characterized by chronic hemolysis, vaso‐occlusive pain crises, and progressive organ damage. Hydroxyurea, often combined with analgesics, remains a mainstay therapy, but may provide insufficient relief during active disease episodes. Drug repurposing...